London Daily

Focus on the big picture.
Wednesday, May 27, 2026

Withholding vaccine safety data ‘morally indefensible,’ medical journal says

Withholding vaccine safety data ‘morally indefensible,’ medical journal says

The British Medical Journal criticized Covid-19 vaccine manufacturers for ‘reaping vast profits’ without proper independent scrutiny

The British Medical Journal (BMJ) has urged public health regulators and pharma majors to immediately release all raw data from Covid-19 vaccine trials for independent scrutiny, arguing that “complete data transparency” was a matter of “public interest.”

Branding Big Pharma as “the least trusted industry,” a recent op-ed by BMJ editors stated that it was “morally indefensible” that this information remains inaccessible to doctors, researchers and the public, despite the global rollout of vaccines and treatments.

In the scathing editorial, the writers – senior BMJ editor Peter Doshi, former editor-in-chief Fiona Godlee and her successor Kamran Abbasi – accuse pharmaceutical companies of “reaping vast profits without adequate independent scrutiny of their scientific claims.”

"At least three of the many companies making Covid-19 vaccines have past criminal and civil settlements costing them billions of dollars. One pleaded guilty to fraud. Other companies have no pre-Covid track record."


In particular, the editorial collective calls out Pfizer, Moderna and AstraZeneca for not providing “timely access” to “anonymized individual participant data” from their clinical trials. This granular data is available to regulators like the US Food and Drug Administration (FDA), which told a judge last month to give it 75 years to publish all data relating to the Pfizer-BioNTech vaccine.

But the BMJ said Pfizer – whose trial was “funded by the company and designed, run, analyzed, and authored by Pfizer employees” – has indicated that it will not entertain data requests until May 2025, a full two years after the primary study is completed.

This lack of access to data is “consistent across vaccine manufacturers,” the editors write, noting that the industry is not “legally required” to honor requests from independent researchers.

Further, they point out that regulatory bodies like Health Canada and the European Medicines Agency do not even “receive or analyze” trial data, whereas the UK’s Medicines and Healthcare Products Regulatory Agency does not “proactively release” such info.

“The purpose of regulators is not to dance to the tune of rich global corporations and enrich them further; it is to protect the health of their populations,” they concluded.

Comments

MHogan 4 year ago
The skeptic in me believes that any negative data — safety or otherwise — released by the FDA or Pharma will have been manipulated beyond recognition from the truth.
mike 4 year ago
The pharmafia works exclusively for Dagobert Duck. People's health doesn't matter.
Maybe omicron will stop this nonsense.

Newsletter

Related Articles

0:00
0:00
Close
'They're people from all walks of life across the UK'
EU Digital ID Claims Misstate What Brussels Can Legally Force on Member States
The Great Western Exit: Why Best Citizens Are Fleeing the Rich World [PODCAST]
The New Robber Barons of Intelligence: Are AI Bosses More Powerful Than Rockefeller?
The End of the Old Order [Podcast]
Britain’s Democracy Is Now a Costume
The AI Gold Rush Is Coming for America’s Last Open Spaces [Podcast]
The Pentagon’s AI Squeeze: Eight Tech Giants Get In, Anthropic Gets Shut Out [Podcast]
The War Map: Professor Jiang’s Dark Theory of Iran, Trump, China, Russia, Israel, and the Coming Global Shock [Podcast]
Labour Is No Longer a National Party [Podcast]
AI Isn’t Stealing Your Job. It’s Dismantling It Piece by Piece.
Lawyers vs Engineers: Why China Builds While America Litigates [Podcast]
Churchill’s Glass: The Drunk, the Doctor, and the Myth Britain Refuses to Sober Up From
Apple issues an unusual warning: this is how your iPhone can be hacked without you doing anything
Kennedy’s Quiet War on Antidepressants Sparks Alarm Across America’s Medical Establishment
The Met Gala Meets the Age of Billionaire Backlash
Russian Oligarch’s Superyacht Crosses Hormuz via Iran-Controlled Route
Gunfire Disrupts White House Correspondents’ Dinner as Trump Is Evacuated
A Leak, a King, and a Fracturing Alliance
Inside the Gates Foundation Turmoil: Layoffs, Scrutiny, and the Cost of Reputational Risk
UK Biobank Breach Exposes Health Data of 500,000, Listed for Sale on Chinese Platform
KPMG Cuts Around 10% of US Audit Partners After Failed Exit Push
French Police Probe Suspected Weather-Data Tampering After Unusual Polymarket Bets on Paris Temperatures
CATL Unveils Revolutionary EV Battery Tech: 1000 km Range and 7-Minute Charging Ahead of Beijing Auto Show
Crypto Scammers Capitalize on Maritime Chaos Near the Strait of Hormuz: A Rising Threat to Shipping Companies
Changi Airport: How Singapore Engineered the World’s Most Efficient Travel Experience
Power Dynamics: Apple’s Leadership Shakeup, Geopolitical Risks in the Strait of Hormuz, and Europe's Energy Strategy Amidst Global Challenges
Apple's Leadership Transition: Can New CEO John Ternus Navigate AI Challenges and Geopolitical Pressures?
Italy’s €100K Tax Gambit: Europe’s Soft Power Tax Haven
News Roundup
Microsoft lost 2.5 millions users (French government) to Linux
Privacy Problems in Microsoft Windows OS
News roundup
Péter András Magyar and the Strategic Reset of Hungary
Hungary After the Landslide — A Strategic Reset in Europe
Meghan Markle Plans Exclusive Women-Focused Retreat During Australia Visit
Starmer and Trump Hold Strategic Talks on Securing Strait of Hormuz Amid Rising Tensions
Unofficial Australia Visit by Prince Harry and Meghan Expected to Stir Tensions with Royal Circles
Pipeline Attack Cuts Significant Share of Saudi Arabia’s Oil Export Capacity
UK Stocks Rise on Ceasefire Momentum and Renewed Focus on Diplomacy
UK to Hold Further Strategic Talks on Strait of Hormuz Security
Starmer Voices Frustration as Global Tensions Drive Up UK Energy Costs
UK Students Voice Concern Over Proposal for Automatic Military Draft Registration
Rising Volatility Drives Uncertainty in UK Fuel and Petrol Prices
UK Moves to Deploy ‘Skyhammer’ Anti-Drone System to Strengthen Airspace Defense
New Analysis Explores UK Budget Mechanics in ‘Behind the Blue’ Feature
Man Arrested After Four Die in Channel Crossing Tragedy
UK Tightens Immigration Framework with New Sponsor Rules and Fee Increases
UK Foreign Secretary Highlights Impact of Intensified Strikes in Lebanon
UK Urges Inclusion of Lebanon in US-Iran Ceasefire Framework
×